Clinical Trial Update: Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis [Phase 4]

View source ↗

Summary

This clinical trial update reports the withdrawal of a Phase 4 safety study evaluating a triple-drug regimen (azithromycin, ivermectin, albendazole) for trachom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Filariasis
• Trachoma

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• Azithromycin (azithromycin)
• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Emory University | Conditions: Trachoma, Lymphatic Filariasis | Phase 4 | Status: WITHDRAWN